BioNTech SE (BNTX) Long-Term Deferred Tax (2019 - 2025)

BioNTech SE (BNTX) has 7 years of Long-Term Deferred Tax data on file, last reported at $15.7 million in Q4 2025.

• For the quarter ending Q4 2025, Long-Term Deferred Tax fell 82.0% year-over-year to $15.7 million; the trailing twelve-month figure through Dec 2025 stood at $15.7 million (down 82.0% YoY), and the FY2025 full-year result was $15.3 million, down 82.53% from the prior year.
• Long-Term Deferred Tax slipped to $15.7 million in Q4 2025, from $20.7 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $346.5 million in Q3 2022 to a low of $15.7 million in Q4 2025.
• A 5-year average of $139.5 million and a median of $98.9 million in 2024 frame the typical range for Long-Term Deferred Tax.
• Across the five-year window, Long-Term Deferred Tax jumped 223.29% in 2023 and slumped 82.0% in 2025, its largest moves.
• Tracing BNTX's Long-Term Deferred Tax over 5 years: stood at $170.9 million in 2021, then surged by 37.05% to $234.2 million in 2022, then tumbled by 62.66% to $87.5 million in 2023, then decreased by 0.19% to $87.3 million in 2024, then tumbled by 82.0% to $15.7 million in 2025.
• Business Quant data shows BNTX's Long-Term Deferred Tax at $15.7 million in Q4 2025, $20.7 million in Q3 2025, and $88.1 million in Q2 2025.